GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a prominent focus in medical studies, largely due to its notable impact on treating ailments such as type 2 diabetes and obesity. Recent trials have demonstrated that more than glucose regulation, GLP-1 agonists of